Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Actinomycin D Workflows for RNA Stability
2026-09-26
Use Actinomycin D to separate altered mRNA decay from changes in transcription, with a practical chase design informed by diabetic vascular calcification research. This guide covers dose selection, solvent handling, controls, interpretation, and ways to limit confounding from transcriptional stress and cytotoxicity.
-
HR Repair Profiling Predicts Olaparib Sensitivity in MPM
2026-09-25
Borchert et al. combined cell-line drug-response experiments with gene-expression profiling of malignant pleural mesothelioma samples to investigate whether homologous recombination defects could indicate olaparib sensitivity. Their results support a BRCAness-based research hypothesis, particularly for BAP1-mutated cells, while emphasizing that gene-expression associations require further functional and clinical validation.
-
Targeted mRNA Therapy After Ischemic Stroke
2026-09-25
Gao and colleagues developed mannose receptor-targeted lipid nanoparticles to deliver IL-10-encoding mRNA to microglia in ischemic brain regions. In mouse stroke models, the approach promoted anti-inflammatory microglial responses, improved blood–brain barrier integrity, and reduced neurological injury, with reported benefit when treatment was initiated as late as 72 hours after stroke.
-
Azumiobodo hoyamushi: Drug Efficacy and Study Findings
2026-09-24
This study compared 20 drugs against Azumiobodo hoyamushi, the protozoan associated with soft tunic syndrome in cultured ascidians, and then tested selected treatments in experimentally infected animals. Fumagillin showed moderate in vitro activity, while formalin and chlorine dioxide reduced parasite numbers in tunic tissue after treatment; the results support further evaluation of disinfection approaches, not a validated farm-wide treatment.
-
Actinomycin D for mRNA Stability in TNBC
2026-09-24
Learn how Actinomycin D can help distinguish altered mRNA stability from transcriptional changes in TNBC research. This guide connects ActD chase design to the YTHDF3–CENPI findings while highlighting controls, interpretation limits, and practical handling.
-
TCAIM Tunes OGDH to Regulate Mitochondrial Metabolism
2026-09-23
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that binds native OGDH and promotes its reduction through HSPA9 and LONP1. The resulting decrease in OGDH complex activity changes carbohydrate catabolism, revealing a protein-turnover mechanism for regulating mitochondrial metabolism.
-
Red Blood Cell Membrane Bending Rigidity
2026-09-23
The reference study isolates the red blood cell cytoplasmic membrane from the spectrin network and ATP-dependent effects to determine its intrinsic bending rigidity. By integrating X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations, the authors estimate a relatively low bending modulus of approximately 4–6 kBT, clarifying why earlier whole-cell measurements varied so widely.
-
Avian Hair-Cell Ablation and Regeneration Protocol
2026-09-22
The reference paper presents an integrated workflow for inducing auditory hair-cell loss in young chickens and simultaneously assessing regenerative responses through multiplexed mRNA detection, immunohistochemistry, and EdU labeling. Its main contribution is methodological: it connects controlled inner-ear injury with spatial, protein-level, and cell-cycle readouts that can improve reproducibility in avian regeneration studies.
-
Temafloxacin Pharmacokinetics and Translational Limits
2026-09-22
The 1991 review of temafloxacin integrates oral and intravenous pharmacokinetics, distribution, elimination, renal function, and dosing implications into a clinically useful framework. Its high bioavailability, approximately 8-hour terminal half-life, and substantial unchanged urinary recovery support flexible dosing, while the healthy-volunteer design also defines important limits for extrapolation to other antimicrobial compounds.
-
Carbapenemase Gene Transmission in CREC, 2022–2024
2026-09-21
Chen et al. mapped carbapenemase-encoding genes, their genomic locations, transferability, and strain relatedness in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. The findings emphasize plasmid-associated blaNDM-1, efficient horizontal dissemination, and the need to combine susceptibility testing with molecular surveillance and infection-control analysis.
-
Apigenin Assay Design: Reliable Cell Data
2026-09-21
This scenario-based guide explains how Apigenin (SKU N1828) can support reproducible cell viability, proliferation, cytotoxicity, and mechanistic assays. It covers dose selection, DMSO handling, assay interpretation, cross-domain evidence, and practical vendor evaluation.
-
Spermine: Mechanism, Benchmarks, and Research Use
2026-09-20
Spermine is an endogenous polyamine that supports eukaryotic cell growth and protein synthesis while modulating inward rectifier potassium channels. The C4910 product is documented for research workflows involving IRK1 channel regulation, cellular metabolism research, and controlled solution preparation.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Assay Guide
2026-09-19
Learn how ARCA Cy3 EGFP mRNA (5-moUTP) separates cellular uptake, endosomal escape, and EGFP reporter gene expression. This assay-focused guide translates recent lipid nanoparticle findings into practical mRNA delivery decisions.
-
N2703 in Adipose-Neural Arrhythmia Research
2026-09-18
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) is a high-purity small-molecule research reagent with documented solvent solubility and refrigerated storage guidance. Its use in adipose-neural cardiac arrhythmia models is hypothesis-driven because the cited preprint establishes the disease pathway but does not report N2703 testing.
-
SpCas9 mRNA: From Chemistry to Translation
2026-09-18
A translational guide to SpCas9 mRNA chemistry, delivery, genome editing performance, and the strategic lessons of lipid nanoparticle-enabled pulmonary editing.